In the study, researchers analyzed 98,529 patients at three U.S. hospitals. Researchers assigned patients into the Medicare allowable fee group (intervention) and the control group.
Here are four takeaways:
1. The intervention and control group had similar pre-intervention order rate trends.
2. Researchers did not note significant changes in overall testing behavior.
3. The intervention group did have a “small but significant” increase in the number of adjusted analysis tests performed over time, compared to the control group.
4. The researchers concluded including the Medicare allowable fees in the EHR for impatient laboratory tests did not result in a substantial change in clinician ordering behavior.
More articles on leadership and management:
5 things to know about Rear Admiral Sylvia Trent-Adams, the new surgeon general
Allergan names Daphne Karydas senior VP of global investor relations: 4 key notes
4 strategies for ASCs to strengthen the patient experience
